12/22
01:07 pm
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/22
01:07 pm
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/22
09:22 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
09:22 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:27 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:27 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:07 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/22
08:07 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/22
07:18 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
12/22
07:03 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/22
06:42 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
06:42 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
06:01 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/19
11:45 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/19
11:45 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/19
11:45 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/18
06:41 am
cytk
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
12/18
06:41 am
cytk
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
12/18
06:41 am
cytk
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
12/12
08:06 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
12/12
05:55 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
12/12
05:55 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
12/1
11:06 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
11/11
10:20 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/11
10:20 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK